Stago launches rapid HIT exclusion test in the UK
28 May 2012
Reading-based Stago has launched a simple test that will
rapidly exclude heparin-induced thrombocytopenia (HIT), following use of
heparin in surgery, in just 10 minutes.
Based on lateral flow technology, the STic Expert HIT kit provides a
quick and easy way of ruling out HIT, allowing clinicians to make
faster, better informed decisions for improved patient care.
HIT is a potentially fatal complication of surgical heparin use,
requiring rapid heparin withdrawal to avoid long term damage, yet
fewer than 10% of patients presenting with symptoms of HIT have
their diagnosis confirmed by laboratory testing.
A rapid and cost-effective test to rule out HIT will avoid the
need for expensive Heparin alternatives and reduces unnecessary
risks to patients suffering from non-heparin associated
The STic Expert HIT kit from Stago is an IgG-specific exclusion
test designed to identify antibodies directed against the
heparin-PF4 complex, offering a simple yet powerful 10-minute test
to rule out HIT.
The company says that each single-use test has been carefully
engineered to achieve excellent sensitivity with a negative
predictive value of 100 %, providing a viable alternative to current
laboratory ELISA tests which can take up to three hours. This rapid
turnaround of results allows clinicians to make an informed decision
on treatment strategies much earlier, offering substantial cost
savings while improving patient safety.
Source: Diagnostica Stago